Sign in
8-K/A

Current Report

BIOCRYST PHARMACEUTICALS INC Filed Acc 0001171843-26-005168

Exit or restructuring costs

  • Item 2.05 Costs associated with exit or disposal activities

From the SEC's structured data for this filing